Cooperative study in the evaluation of therapy in multiple sclerosis: ACTH vs placebo in acute exacerbation.

No abstract is available for this paper.

• Publication year

  1969

• Venue

  Transactions of the American Neurological Association

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 4313957
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Role of Melanocortins in Inflammation and Other Therapeutic Indications Like Pulmonary Inflammatory, Allergic and Neurological Disorders Like Multiple Sclerosis, Infantile Spasms and Brain Injury-A Systematic Review

  2020cites this paper
• DNND_A_208815 55..78

  2019cites this paper
• Efficacy, safety, and quality-of-life of treatments for acute relapses of multiple sclerosis: results from a literature review of randomized controlled trials

  2019cites this paper
• life of treatments for acute relapses of multiple sclerosis : results from a literature review of randomized controlled trials

  2019cites this paper
• Clinical trials in multiple sclerosis: milestones

  2018cites this paper
• Assessment and Treatment Strategies for a Multiple Sclerosis Relapse.

  2018cites this paper
• A 52-Year-Old Woman With Diabetes and Claudication, 1 Year Later

  2016cites this paper
• William Austin Sibley, MD (1925–2015)

  2016cites this paper
• Treatment of Acute Relapses in Multiple Sclerosis

  2012cites this paper
• Milestones in Neurology in the Last 50 Years on Multiple Sclerosis

  2010cites this paper
• Current and Future Role of Interferon Beta in the Therapy of Multiple Sclerosis

  2010cites this paper
• Spotlight series: pivotal trials through today's knowledge--adrenocorticotrophic hormone.

  2009cites this paper
• Historical and Clinical Perspectives of the Expanded Disability Status Scale

  2008cites this paper
• Slowing the Progression of Multiple Sclerosis

  2005cites this paper
• Syndrome of Infant Botulism

  2005cites this paper
• EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses

  2005cites this paper
• Autologous Lymphocyte ProMeration in Multiple Sclerosis

  2004cites this paper
• Steriods for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials

  2000cites this paper
• Natural history and clinical outcome measures for multiple sclerosis studies.¶Why at the present time does EDSS scale remain a preferred outcome measure to evaluate disease evolution?

  2000cites this paper
• Applications of Human Performance Measurements to Clinical Trials to Determine Therapy Effectiveness and Safety

  1999cites this paper
• Perils and Pitfalls in the Interpretation of Clinical Trials: A Reflection on the Recent Experience in Multiple Sclerosis

  1999cites this paper
• Pregnancy outcome following first trimester exposure to sumatriptan

  1998cites this paper
• Selecting Neurologic Function Tests for Parkinson’s Disease: A Primer

  1995cites this paper
• High‐dose glucocorticoids in multiple sclerosis patients exert direct effects on the kidney and skeleton

  1994cites this paper
• Role of steroids and immunosuppression and effects of interferon beta-1b in multiple sclerosis.

  1994cites this paper
• The use of immunosuppressive agents in the treatment of multiple sclerosis

  1991cites this paper
• Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: A randomized, double‐blinded, placebo‐controlled clinical trial

  1990cites this paper
• Immunotherapy of multiple sclerosis

  1988cites this paper
• Plasmapherese-/Lymphozytapherese-Behandlung bei Multipler Sklerose - Was ist gesichert?

  1988cites this paper
• Leigh syndrome, a mitochondrial encephalo(myo)pathy. A review of the literature.

  1987cites this paper
• Efficacy of Intrathecally Administered Natural Human Fibroblast Interferon as Treatment of Multiple Sclerosis

  1987cites this paper
• Cyclophosphamide 'pulses' in chronic progressive multiple sclerosis. A preliminary clinical trial.

  1987cites this paper
• Serial Recordings of Multimodality Evoked Potentials in Multiple Sclerosis: A Four Year Follow-Up Study

  1986cites this paper
• Benefits, risks and costs of immunization for measles, mumps and rubella.

  1985cites this paper
• Acute improvement in exacerbating multiple sclerosis produced by intraenous administration of mannitol

  1985cites this paper
• Verapamil-induced changes in central conduction in patients with multiple sclerosis.

  1985cites this paper
• Editorial Review: Therapeutic Trials in Multiple Sclerosis

  1984cites this paper
• Intrathecal interferon as treatment of multiple sclerosis. A planned multicenter study.

  1983cites this paper
• Scoring techniques and problems in the evaluation of change in patients.

  1983cites this paper
• Myoclonus in a case of suspected progressive rubella panencephalitis.

  1983cites this paper
• Immunosuppression and plasmapheresis in chronic progressive multiple sclerosis. Design of a clinical trial.

  1983cites this paper
• Intrathecal interferon for multiple sclerosis.

  1982cites this paper
• Effect of ACTH treatment on CSF and blood lymphocyte subpopulations in patients with multiple sclerosis

  1981cites this paper
• Intrathecal interferon reduces exacerbations of multiple sclerosis.

  1981cites this paper
• Two cases of rapidly progressive subacute sclerosing panencephalitis. Neuropathological findings.

  1981cites this paper
• Autologous lymphocyte proliferation in multiple sclerosis and the effect of intravenous ACTH

  1981cites this paper
• Blood lymphocyte subpopulations show characteristic changes during ACTH therapy in acute exacerbations of multiple sclerosis

  1980cites this paper
• Failure of intravenous and intrathecal cytarabine to modify central nervous system IgG synthesis in multiple sclerosis

  1980cites this paper
• Feveal versus peripheral retinal responses: A new analysis for early diagnosis of multiple sclerosis

  1979cites this paper
• Evidence for lack of synthesis of the M polypeptide of measles virus in brain cells in subacute sclerosing panencephalitis.

  1979cites this paper
• Foveal versus peripheral retinal responses: a new analysis for early diagnosis of multiple sclerosis.

  1979cites this paper
• Immune Complexes and Tissue Injury

  1979cites this paper
• Linoleic acid in multiple sclerosis: Failure to show any therapeutic benefit

  1978cites this paper
• Cell‐mediated immunity to measles virus in multiple sclerosis

  1978cites this paper
• Improvement in multiple sclerosis during prolonged induced hypothermia

  1977cites this paper
• Unconventional viruses and the origin and disappearance of kuru.

  1977cites this paper
• Comparison of dantrolene sodium and diazepam in the treatment of spasticity.

  1976cites this paper
• Multiple sclerosis: immunologic aspects.

  1975cites this paper
• Subacute necrotizing encephalomyelopathy. Rapidly fatal course of Leigh disease in a 5-year-old child.

  1974cites this paper
• Quantitative evaluation of neuropharmacological trials

  1974cites this paper
• Editorial: Koch's postulates and slow infections of the nervous system.

  1974cites this paper
• STUDIES ON THE NATURAL HISTORY OF MULTIPLE SCLEROSIS: 7. Correlates of Clinical Change in an Early Bout

  1973cites this paper
• SUBJECT REVIEW

  1969cites this paper
• An assessment of the reliability of three methods used in evaluating the status of multiple sclerosis patients.

  1969cites this paper